As an example of a combined GLP-1 + FIM intervention, eligible patients could receive both GLP-1 therapy and a FIM intervention emphasizing foods to support weight maintenance, reduce side effects, minimize loss of muscle and bone mass, and promote nutrient adequacy
Optimal dosing, long-term safety, and consistent effectiveness in IBS patients remain unclear
Clinically, the patch becomes raised, lumpy or ulcerated
Safety Considerations and Who May Benefit Whilst GLP-1 receptor agonists are generally well-tolerated, understanding their adverse effect profile is essential for appropriate patient selection and monitoring
doi: 10.1158/1940-6207.capr-16-0249 238 BenitezAJHoffmannCMuirABDodsKKSpergelJMBushmanFDet al
When It May Not Fit Belle is not suitable for people who need in person medical supervision or frequent hands on monitoring